ID3 and melanoma: Inhibitor of differentiation protein 3 (ID3) is another player highly involved in phenotype switching; the transcription profiling of 21 BRAF-mutated melanomas revealed an upregulation of ID3 in BRAF inhibitor (BRAFi)-resistant tumors compared to treatment-naïves.